Astrazeneca AZN Cash Flow Statement (2009-2026)

NYSE AZN
$160.15 +0.51 (+0.32%)
As of: Sep 11, 2026 · 3:59 PM EDT
Reported Financials

Astrazeneca Quarterly Cash Flow Statement

Periods 70 quarters
Latest Jun 2026

Astrazeneca reported cash from operations of $2.87B and free cash flow of $3.63B for the quarter ended Jun 2026, down 15.4% year over year. This cash flow statement covers 70 quarters of results from Mar 2009 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Mar2009 Jun2009 Sep2009 Dec2009 Mar2010 Jun2010 Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-2.35B-0.93B0.72B0.13B0.20B0.65B2.72B2.36B1.93B7.00B3.42B2.87B2.22B1.83B3.88B3.81B3.95B14.10B4.75B3.09B
Share-based CompensationStock Comp.
Gains from Sales and DivestituresGains Divest
-0.02B-0.37B-0.01B-0.07B-0.09B-0.25B-0.25B-0.01B-0.06B-0.07B-0.02B-0.03B-0.05B-0.03B-0.09B
Gains from Investment SecuritiesGains Investment
-0.05B0.03B0.29B0.20B0.02B0.23B0.06B0.00B-0.03B0.00B-0.07B0.00B-0.02B
Asset Writedowns and ImpairmentWritedown
Cash from Restructuring
Cash from OperationsCash from Ops.
1.72B1.42B3.23B1.25B7.41B3.13B1.72B7.96B2.49B3.08B3.38B2.91B3.71B3.39B5.13B2.34B3.36B2.87B
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF)Dep. & Amort.
2.79B2.19B1.31B1.36B4.00B1.50B1.28B4.06B1.25B1.28B1.82B2.34B1.28B1.39B1.55B1.51B1.37B1.93B
Change in Working Capital
Change in TaxesChange Taxes
-0.33B-0.55B-0.23B-0.78B-0.23B-0.84B-0.43B-0.91B-0.64B-0.77B-0.36B-1.19B-0.64B-0.65B-0.53B-1.52B
Other Working Capital ChangesOther WC Changes
1.21B
Investing Activities
Capital ExpendituresCapex
-0.26B-0.32B-0.22B-0.25B-0.25B-0.27B-0.42B-0.38B-0.42B-0.71B-0.43B-0.66B-0.69B-1.04B-0.55B-0.76B
Sales of Property, Plant and EquipmentPP&E (Sale)
0.01B0.00B0.12B0.00B0.05B0.00B0.00B0.01B0.00B0.01B0.00B
Change in IntangiblesChange Intangibless
0.01B0.00B0.39B0.06B0.26B0.02B0.07B0.03B0.02B0.01B0.09B0.00B0.04B0.04B0.12B
Acquisitions
-0.19B-0.73B-2.04B-0.01B
Divestments
0.34B
Cash from Investing ActivitiesCash from Investing
-10.46B-0.91B-0.17B-0.80B-1.25B-0.52B-2.41B-2.87B-1.51B-1.18B-1.25B-2.11B-2.00B-1.45B-1.79B-2.91B
Financing Activities
Other financing activitiesOther financing
Cash from Financing ActivitiesCash from Financing
-8.74B-5.60B3.06B0.45B4.70B1.89B1.20B4.98B0.07B0.21B1.87B1.73B2.46B1.28B3.13B0.90B1.57B-0.05B
Change in Capital Stock
Net Shares Issued and RepurchasedNet Shares Issued
Net Equity Issued and RepurchasedNet Equity Issued
0.00B0.02B0.01B0.00B0.00B0.00B0.01B0.01B0.00B0.02B0.01B0.00B0.01B0.02B0.01B0.01B
Dividend Payments
Dividends Paid - CommonDiv. Paid (Common)
-1.39B-2.97B-3.05B-0.02B-3.03B-0.02B-1.58B-0.00B-3.35B-0.01B-1.61B-0.00B-3.29B-0.00B
Additional items
Exchange Rate EffectFX Effect
-0.02B0.01B-0.01B-0.03B-0.01B-0.04B-0.05B-0.01B0.02B-0.06B0.03B0.03B-0.01B0.00B-0.02B0.01B
Change in Cash
-8.02B6.04B6.23B-0.25B7.84B-6.75B4.54B5.43B1.63B1.08B-2.44B7.56B-1.86B
Beginning Cash Balance
Free Cash FlowFCF
1.98B1.74B3.45B1.50B7.41B3.38B1.99B7.96B2.90B3.47B3.80B3.62B4.14B4.04B5.82B3.38B3.91B3.63B
Net Cash FlowNCF
-17.49B-5.09B6.13B0.90B12.11B3.77B2.40B12.94B0.15B0.43B3.74B3.45B4.92B2.56B6.27B1.79B3.13B-0.09B